MC Explains | GEMCOVAC-19, India's first mRNA Covid-19 vaccine, and how it scores over Pfizer, Moderna
Apart from being indigenously developed, the vaccine is available in powdered form without the need to be stored at sub-zero temperatures, making it easy to transport to remote areas
Omicron-targeting Covid vax shows high immune response: Pfizer & BioNTech
A booster dose of the Omicron-adapted bivalent candidates conferred a 9.1 and 10.9-fold increase in neutralising antibodies against Omicron BA.1, that was circulating last winter
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholder(s).
US FDA authorizes Covid-19 vaccines for kids as young as 6 months
The US Food and Drug Administration (FDA) has authorized emergency use of the Moderna and Pfizer-BioNTech Covid-19 vaccines for children as young as 6 months, the first for kids in this age group
USFDA authorises first coronavirus shots for infants, preschoolers
The Food and Drug Administration's action follows its advisory panel's unanimous recommendation for the shots from Moderna and Pfizer
US FDA advisers approve Moderna, Pfizer vaccines for kids under 5
COVID-19 shots for US infants, toddlers and preschoolers moved a step closer Wednesday
Pfizer's Covid vaccine safe and effective for kids under 5: US FDA
The US Food and Drug Administration (FDA) said that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children under 5-years-old
COVID-19: Pfizer vaccines safe for small children, says FDA
The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.
FDA advisers back Novavax's Covid vaccine shots as 4th US option
American adults who haven't yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorise the protein vaccine made by latecomer Novavax as the nation's fourth coronavirus shot for adults. It's made with more conventional technology than today's dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option. Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial vaccinations or as mix-and-match boosters. But U.S. clearance is a key hurdle for the Maryland-based company. FDA's vaccine chief Dr. Peter Marks said another choice in the U.S. may entice at least some vaccine holdouts -- whatever their reason -- to consider rolling up their sleeves. We do have a problem with vaccine uptake that is very serious in the United States," Marks said. "Anything w PFIZER LTD. - 500680 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2022. The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com